Gastrointestinal adverse events and weight reduction in people with type 2 diabetes treated with tirzepatide in the SURPASS clinical trials.
使用 Tirzepatide 治療的第2型糖尿病患者在 SURPASS 臨床試驗中的胃腸不良事件和體重減輕。
Diabetes Obes Metab 2024-01-22
Gastrointestinal adverse events of tirzepatide in the treatment of type 2 diabetes mellitus: A meta-analysis and trials sequential analysis.
Tirzepatide 在治療第2型糖尿病中的胃腸道不良事件:一項荟萃分析和試驗序列分析。
Medicine (Baltimore) 2024-02-08
Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: a systematic review and meta-analysis.
Tirzepatide(胰臟炎和膽囊或膽道疾病)在2型糖尿病和肥胖中的安全問題:系統回顧和荟萃分析。
Front Endocrinol (Lausanne) 2024-03-29
A Case Report of Systemic Allergic Reaction to the Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonist Tirzepatide.
對雙糖依賴性胰島素促泌肽/葡萄糖樣胰高血糖素-1受體激動劑 Tirzepatide 引起全身過敏反應之病例報告。
Cureus 2024-02-02
Dramatic Changes in Thiopurine Metabolite Levels in a Patient With Inflammatory Bowel Disease Treated With Tirzepatide for Weight Loss.
使用 Tirzepatide 減重的炎症性腸病患者硫嘌呤代謝物水平的劇變。
ACG Case Rep J 2024-11-07